You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET gene mutation

Showing 1 - 25 of 9,425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

Non Small Cell Lung Cancer, Ovarian Cancer, RET Gene Mutation Trial in New York (RXDX-105)

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center 1275 York Avenue
Sep 30, 2020

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

NSCLC, Thyroid Tumors Trial (LOXO-260)

Temporarily not available
  • Carcinoma, Non-Small-Cell Lung
  • Thyroid Neoplasms
  • (no location specified)
Sep 20, 2022

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

Homologous Recombination Repair Pathway Gene Mutation Spectrum

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 4, 2023

    Cancer Trial (Dabrafenib, Trametinib)

    Not yet recruiting
    • Cancer
    • (no location specified)
    May 25, 2023

    Gene Mutation Trial in Beijing (RAG-17)

    Enrolling by invitation
    • Gene Mutation
    • Beijing, China
      Beijing Tiantan Hospital
    Jun 11, 2023

    AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

    Not yet recruiting
    • AXIN1 Gene Mutation
    • +2 more
    • (no location specified)
    Aug 21, 2023

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Colorectal Carcinoma, Liver Metastases Trial in Shanghai (anatomical liver resection, nonanatomical liver resection)

    Not yet recruiting
    • Colorectal Carcinoma
    • Liver Metastases
    • anatomical liver resection
    • nonanatomical liver resection
    • Shanghai, Shanghai, China
      Zhongshan hospital
    May 21, 2023

    DDX41 Gene Mutation Trial in France (For each person (index case or related) included in this study:)

    Not yet recruiting
    • DDX41 Gene Mutation
    • For each person (index case or related) included in this study:
    • Bordeaux, France
    • +4 more
    Aug 28, 2023

    Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit

    Not yet recruiting
    • Helicobacter Pylori Infection
    • +3 more
    • Detection of fecal samples with diagnostic kit
    • +2 more
    • (no location specified)
    Jun 5, 2022

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)

    Recruiting
    • Biallelic RPE65 Mutation-associated Retinal Dystrophy
    • FT-001 Low Dose
    • +2 more
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 11, 2023

    Patients With a Constitutional Alteration of the PTEN Gene

    Not yet recruiting
    • PTEN Gene Mutation
      • (no location specified)
      Nov 17, 2022

      ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

      Recruiting
      • ATM Gene Mutation
      • +16 more
      • Sacramento, California
        University of California Davis Comprehensive Cancer Center
      Oct 27, 2022

      TRPV4 Gene Mutation Trial

      Not yet recruiting
      • TRPV4 Gene Mutation
        • (no location specified)
        Jan 9, 2023

        Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

        Active, not recruiting
        • Advanced Nonhaematologic Malignancies
        • Philadelphia, Pennsylvania
        • +20 more
        Sep 23, 2022

        Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

        Not yet recruiting
        • Leber Hereditary Optic Neuropathy (LHON)
        • NFS-02 Injection
        • (no location specified)
        Apr 6, 2023

        Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

        Recruiting
        • Metastatic Solid Tumor
        • +4 more
        • Recommendation for treatment with immunotherapy
        • Baltimore, Maryland
          Johns Hopkins University
        Sep 8, 2022

        NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

        Recruiting
        • Non-Small Cell Lung Cancer
        • +5 more
        • Toripalimab
        • +3 more
        • Guanzhou, Guangdong, China
          Guangdong Lung Cancer Institute, Guangdong Provincial People's H
        Apr 4, 2023

        Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

        Not yet recruiting
        • Metastatic Solid Tumor
        • +4 more
        • San Francisco, California
          University of California, San Francisco
        Jan 12, 2023